Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome

Published:2015-08-20 Issue:2 Volume:30 Page:325-330
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tambaro F P,Garcia-Manero G,O'Brien S M,Faderl S H,Ferrajoli A,Burger J A,Pierce S,Wang X,Do K-A,Kantarjian H M,Keating M J,Wierda W G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2015227.pdf

Reference20 articles.

1. Wiernik PH . Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options Oncol 2004; 5: 215–223.

2. Badoux XC, Keating MJ, Wang X, O'Brien SM, Ferrajoli A, Faderl S et al. Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL. Blood 2011; 117: 3016–3024.

3. Carney DA, Westerman DA, Tam CS, Milner A, Prince HM, Kenealy M et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. Leukemia 2010; 24: 2056–2062.

4. Cheson BD, Vena DA, Barrett J, Freidlin B . Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J Clin Oncol 1999; 17: 2454–2460.

5. Colovic M, Suvajdzic N, Jankovic G, Tomin D, Colovic N, Fekete MD et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide. Biomed Pharmacother 2011; 65: 319–321.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of venetoclax and rituximab in the treatment of concurrent acute myeloid leukemia and untreated chronic lymphocytic leukemia: A case report and literature review;Oncology Letters;2024-06-25

2. With great power comes great responsibility: Managing side effects of novel treatments in chronic lymphocytic leukemia (CLL);Canadian Hematology Today;2022-07-01

3. Identification of two downregulated circRNAs in patients with acute B‑lymphocytic leukemia;Oncology Letters;2021-12-03

4. Multi Cytogenetic Changes in a Patient as Co-Existing MDS and CLL Progresses;OncoTargets and Therapy;2021-01

5. CLL dedifferentiation to clonally related myeloid cells;Blood Advances;2020-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3